Carpentier-Edwards Bioprosthesis Edwards Lifesciences’ porcine valves combine rigorous tissue selection, fixation technology and advanced manufacturing components that have set the industry standard. Our Carpentier-Edwards valves feature: New Patented Edwards XenoLogiX Treatment – Significantly reduced calcification in rat and sheep implant studies. 1,2 * Proven Fixation Technology – Original fixation process that remains the foundation of tissue preservation today. – Minimizes alterations in the collagen waveform and increases leaflet compliance Specialized Construction – Asymmetrical stent conforms to the natural porcine valve geometry. – Obstruction of the orifice is prevented by sewing the muscle shelf into the stent wall. Compliant Sewing Ring – Aortic – scalloped design conforms to the contoured shape of the annulus. – Mitral – broad flat design facilitates secure implant onto the annulus. Elgiloy Stent – Flexible material minimizes tissue stress. – Superior spring efficiency reduces creep. *No clinical data are available which evaluate the long-term impact of the XenoLogiX treatment in patients.

Carpentier-Edwards Bioprosthesis Aortic Model 2625 and Mitral Model 6625 Proven 15 year Durability in Patients > 70 years.3 89% Mitral Actuarial Freedom (%) from Structural Valve Deterioration Actuarial Freedom (%) from Structural Valve Deterioration ”The [Carpentier-Edwards Bioprosthesis] is recommended for aortic valve replacement for patients older than 70 years and for 4 patients 61-70 (when extended longevity is not anticipated) and for mitral valve replacement for patients older than 70 years. “ Specifications Significant dimensions in millimeters (nominal values) Edwards TRUE-SIZE Aortic...